Haiming Wei

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 18

Top Topics

Natural Killer Cells

Signaling Pathway

Peripheral Blood

Top Venues

Nature communications

Nature immunology

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Shushu Wang, Dongyao Wang, Xuesong Wang, Mingwu Chen, Yanshi Wang, Haoquan Zhou, Yonggang Zhou, Yong Lv, Haiming Wei
Cytokine Storm Related to CD4 + T Cells in Influenza Virus-Associated Acute Necrotizing Encephalopathy. Immune network 24 (2) (2024)
Shushu Wang, Dongyao Wang, Xuesong Wang, Mingwu Chen, Yanshi Wang, Haoquan Zhou, Yonggang Zhou, Yong Lv, Haiming Wei
Cytokine Storm Related to CD4 + T Cells in Influenza Virus-Associated Acute Necrotizing Encephalopathy. Immune network 24 (2) (2024)
Hongdi Ma, Xuben Wang, Xiaohu Zheng, Haiming Wei
Sphingomyelin is a prospective metabolic immune checkpoint for natural killer cells. Clinical and translational medicine 13 (9) (2023)
Jing Jin, Lin Bai, Dongyao Wang, Wei Ding, Zhuoxian Cao, Peidong Yan, Yunjia Li, Lulu Xi, Yuxin Wang, Xiaohu Zheng, Haiming Wei, Chen Ding, Yi Wang
SIRT3-dependent delactylation of cyclin E2 prevents hepatocellular carcinoma growth. EMBO reports (2023)
Dongyao Wang, Haiming Wei
Natural killer cells in tumor immunotherapy. Cancer biology & medicine (2023)
Yiqing Shen, Xiaohu Zheng, Yeben Qian, Mantian Liu, Zhigang Nian, Quanwei Cui, Yonggang Zhou, Binqing Fu, Rui Sun, Zhigang Tian, Haiming Wei
Interactions between driver genes shape the signaling pathway landscape and direct hepatocellular carcinoma therapy. Cancer science (2023)
Xiaohu Zheng, Zhuanghao Hou, Yeben Qian, Yongwei Zhang, Quanwei Cui, Xuben Wang, Yiqing Shen, Zhenbang Liu, Yonggang Zhou, Binqing Fu, Rui Sun, Zhigang Tian, Guangming Huang, Haiming Wei
Tumors evade immune cytotoxicity by altering the surface topology of NK cells. Nature immunology (2023)
Yawen Chen, Xianwei Wang, Xiaolei Hao, Bin Li, Wanyin Tao, Shu Zhu, Kun Qu, Haiming Wei, Rui Sun, Hui Peng, Zhigang Tian
Ly49E separates liver ILC1s into embryo-derived and postnatal subsets with different functions. The Journal of experimental medicine 219 (5) (2022)
Defeng Jiao, Xiaohu Zheng, Xianghui Du, Dong Wang, Ziming Hu, Rui Sun, Zhigang Tian, Binqing Fu, Haiming Wei
Immunogenic senescence sensitizes lung cancer to LUNX-targeting therapy. Cancer immunology, immunotherapy : CII (2021)
Xiwei Wang, Zheng Xiang, Yinping Liu, Chunyu Huang, Yujun Pei, Xia Wang, Hui Zhi, Wilfred Hing-Sang Wong, Haiming Wei, Irene Oi Lin Ng, Pamela Pui-Wah Lee, Godfrey Chi-Fung Chan, Yu-Lung Lau, Wenwei Tu
Exosomes derived from Vδ2-T cells control Epstein-Barr virus-associated tumors and induce T cell antitumor immunity. Science translational medicine 12 (563) (2021)
Lu Bai, Margaux Vienne, Ling Tang, Yann M Kerdiles, Marion Etiennot, Bertrand Escalière, Justine Galluso, Haiming Wei, Rui Sun, Éric Vivier, Hui Peng, Zhigang Tian
Liver type 1 innate lymphoid cells develop locally via an interferon-γ-dependent loop. Science (New York, N.Y.) 371 (6536) (2021)
Hao Song, Jiaxi Song, Ming Cheng, Meijuan Zheng, Tian Wang, Sha Tian, Richard A Flavell, Shu Zhu, Hua-Bing Li, Chen Ding, Haiming Wei, Rui Sun, Hui Peng, Zhigang Tian
METTL3-mediated m6A RNA methylation promotes the anti-tumour immunity of natural killer cells. Nature communications 12 (1) (2021)
Yonggang Zhou, Binqing Fu, Xiuxiu Xu, Jinghe Zhang, Xianhong Tong, Yanshi Wang, Zhongjun Dong, Xiaoren Zhang, Nan Shen, Yiwen Zhai, Xiangdong Kong, Rui Sun, Zhigang Tian, Haiming Wei
PBX1 expression in uterine natural killer cells drives fetal growth. Science translational medicine 12 (537) (2021)
Linlin Jin, Zimin Sun, Huilan Liu, Xiaoyu Zhu, Yonggang Zhou, Binqing Fu, Xiaohu Zheng, Kaidi Song, Baolin Tang, Yun Wu, Jiang Zhu, Rui Sun, Zhigang Tian, Haiming Wei
Inflammatory monocytes promote pre-engraftment syndrome and tocilizumab can therapeutically limit pathology in patients. Nature communications 12 (1) (2021)
Binqing Fu, Xiaoling Xu, Haiming Wei
Why tocilizumab could be an effective treatment for severe COVID-19? Journal of translational medicine 18 (1) (2020)
Haiming Wei, Binqing Fu
Make killers sweeter: targeting metabolic checkpoints of NK cells. Nature immunology 21 (9) (2020)
Chuang Guo, Bin Li, Huan Ma, Xiaofang Wang, Pengfei Cai, Qiaoni Yu, Lin Zhu, Liying Jin, Chen Jiang, Jingwen Fang, Qian Liu, Dandan Zong, Wen Zhang, Yichen Lu, Kun Li, Xuyuan Gao, Binqing Fu, Lianxin Liu, Xiaoling Ma, Jianping Weng, Haiming Wei, Teng-Chuan Jin, Jun Lin, Kun Qu
Single-cell analysis of two severe COVID-19 patients reveals a monocyte-associated and tocilizumab-responding cytokine storm. Nature communications 11 (1) (2020)
Xiaohu Zheng, Yeben Qian, Binqing Fu, Defeng Jiao, Yong Jiang, Peng Chen, Yiqing Shen, Huafeng Zhang, Rui Sun, Zhigang Tian, Haiming Wei
Mitochondrial fragmentation limits NK cell-based tumor immunosurveillance. Nature immunology 20 (12) (2019)